A Th2 immune shift to heat shock protein 65 fails to arrest atherosclerosis: Proatherogenic role of Th2-deviated autoantibodies

Autoimmunity

Volumn 42, Issue 6, 2009, Pages 475-483

  Xiong, Qiyan ^a   Jin, Liang ^a   Li, Jianping ^a   Fan, Hao ^b   Cao, Rongyue ^a   Wu, Jie ^a   Li, Taiming ^a   Liu, Jingjing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Shanghai Yijiu Biomedical Cooperation Ltd   (China)

Author keywords

Atherosclerosis; Autoantibodies; Cytotoxicity; Heat shock protein 65; Th2 shift

Indexed keywords

AUTOANTIBODY; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 65 ANTIBODY; HYBRID PROTEIN; IMMUNOGLOBULIN G1; INTERLEUKIN 10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL DAMAGE; CELL SPECIFICITY; CELL STRESS; COMPLEMENT FACTOR; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ANIMALS; AORTA; ATHEROSCLEROSIS; AUTOANTIBODIES; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HEAT-SHOCK PROTEINS; HUMANS; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; RABBITS; TH1 CELLS; TH2 CELLS; UMBILICAL VEINS;

EID: 70249135606     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902887086     Document Type: Article

References (28)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-1695.
2. Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis 2008;1:17-32.
3. Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002;105:1012-1017.
4. Ford P, Gemmell E, Walker P, West M, Cullinan M, Seymour G. Characterization of heat shock protein-specific T cells in atherosclerosis. Clin Diagn Lab Immunol 2005;12:259-267.
5. Jones DB, Hunter NR, Duff GW. Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. Lancet 1990;336:583-585.
6. Tong L, Moudgil KD. Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Res Ther 2007;9:R70.
7. Gao YL, Brosnan CF, Raine CS. Experimental autoimmune encephalomyelitis. Qualitative and semiquantitative differences in heat shock protein 60 expression in the central nervous system. J Immunol 1995;154:3548-3556.
8. Frostegård J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999;145:33-43.
9. Benagiano M, Azzurri A, Ciervo A, Amedei A, Tamburini C, Ferrari M, Telford JL, Baldari CT, Romagnani S, Cassone A, D'Elios MM, Del Prete G. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci U S A 2003;100:6658-6663.
10. Huurman VA, van der Meide PE, Duinkerken G, Willemen S, Cohen IR, Elias D, Roep BO. Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin Exp Immunol 2008;152:488-497.
11. Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996;183:1561-1567.
12. Ruiz PJ, Garren H, Ruiz IU, Hirschberg DL, Nguyen LV, Karpuj MV, Cooper MT, Mitchell DJ, Fathman CG, Steinman L. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: Modulation of T-cell costimulation. J Immunol 1999;162:3336-3341.
13. Im SH, Barchan D, Fuchs S, Souroujon MC. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. J Clin Invest 1999;104:1723-1730.
14. Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995;96:2569-2577.
15. Xu Q, Schett G, Seitz CS, Hu Y, Gupta RS, Wick G. Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 1994;75:1078-1085.
16. Foteinos G, Afzal AR, Mandal K, Jahangiri M, Xu Q. Antiheat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation 2005;112:1206-1213.
17. Schett G, Metzler B, Mayr M, Amberger A, Niederwieser D, Gupta RS, Mizzen L, Xu Q, Wick G. Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 1997;128:27-38.
18. Jin L, Wang Y, Xiong Q, Chen Q, Li J, Zhu A, Cao R, Wu J, Liu J. Long-lasting specific antibodies against P277 induced by mucosal administration of P277 repeat sequences carried by Hsp65 in the absence of adjuvants. Vaccine 2007; 25:2043-2050.
19. Jin L, Zhu A,Wang Y, Chen Q, Xiong Q, Li J, Sun Y, Li T, Cao R,Wu J, Liu J. ATh1-recognized peptide P277, when repeated in tandem, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in non-obese diabetic mice. J Immunol 2008;180:58-63.
20. Maron R, Sukhova G, Faria AM, Hoffmann E, Mach F, Libby P, Weiner HL. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 2002;106:1708-1715.
21. Quintana FJ, Rotem A, Carmi P, Cohen IR. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in non-obese diabetic mice: Modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol 2000;165:6148-6155.
22. Bockova J, Elias D, Cohen IR. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. J Autoimmun 1997;10:323-329.
23. Lyons JA, RamsbottomMJ, Cross AH. Critical role of antigenspecific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur J Immunol 2002;32:1905-1913.
24. Pfister G, Stroh CM, Perschinka H, Kind M, Knoflach M, Hinterdorfer P, Wick G. Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. J Cell Sci 2005;118:1587-1594.
25. Morris-Downes MM, Smith PA, Rundle JL, Piddlesden SJ, Baker D, Pham-Dinh D, Heijmans N, Amor S. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice. J Neuroimmunol 2002; 125:114-124.
26. Kidd P. Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003;8:223-246.
27. Pedotti R, Mitchell D, Wedemeyer J, Karpuj M, Chabas D, Hattab EM, Tsai M, Galli SJ, Steinman L. An unexpected version of horror autotoxicus: Anaphylactic shock to a selfpeptide. Nat Immunol 2001;2:216-222.
28. Liu E, Moriyama H, Abiru N, Miao D, Yu L, Taylor RM, Finkelman FD, Eisenbarth GS. Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin selfpeptides B:9-23 and B:13-23. J Clin Invest 2002; 110:1021-1027.